Today @ Colorado State has been replaced by SOURCE. This site exists as an archive of Today @ Colorado State stories between January 1, 2009 and September 8, 2014.

Veterinary Medicine

CSU commemorates World TB Day

March 25, 2013
by Tasia DeMuth

CSU's internationally acclaimed tuberculosis researchers are commemorating World Tuberculosis Day - officially March 24 - today to educate and raise awareness about tuberculosis.

TB professor Mary Jackson with her laboratory team in CSU's Mycobacteria Research Laboratories.CSU is hosting an event for high school students to see its research laboratories in action and talk with some of the top researchers in the TB field. Speakers include CSU President Tony Frank, Mycobacteria Research Laboratories co-founder Patrick Brennan, and Mycobacteria Research Laboratories director Mary Jackson.

Following tours, students will have a chance for informal discussion with researchers and their science teachers.

Researchers on Sunday hosted "Bacteria Wars" at the Fort Collins Museum of Discovery to teach children of all ages about tuberculosis and other diseases.

International research center

CSU is home to the Mycobacteria Research Laboratories which includes the Rocky Mountain Regional Biocontainment Laboratory, where researchers work with drug-resistant tuberculosis and other infectious diseases.

The Mycobacteria Research Laboratories hosts 30,000 square feet of laboratory space and employs 163 researchers dedicated to discovering treatments, diagnostics and vaccines to combat tuberculosis. CSU is an international leader in TB, a disease that kills 1.4 million globally every year. Scientists at CSU helped test the first new anti-tuberculosis drug approved by the Federal Drug Administration in 40 years. This discovery is imperative to fighting multi-drug resistant tuberculosis, of which there are an estimated 630,000 cases worldwide.

Vaccines tested at CSU are now in clinical trials in South Africa. The university helps test anti-tuberculosis compounds for laboratories around the world and facilitates TB research in laboratories globally through the provision of specific research materials. Between 2006 and 2009, CSU’s Mycobacteria Research Laboratories served more than 600 international labs in 44 countries.

Because of CSU’s extensive research, the team receives significant funding from the National Institutes of Health, the Food and Drug Administration, the Bill and Melinda Gates Foundation, and the Global Alliance for TB Drug Development. The university’s tuberculosis researchers have received over $93 million in funding since 1981.


Contact: Emily Wilmsen
E-mail: Emily.Wilmsen@colostate.edu
Phone: (970) 491-2336